Reading width
13Immunology14 min read

Antiphospholipid syndrome

1. Big picture

Antiphospholipid syndrome (APS) is an autoimmune acquired thrombophilia. The key paradox is:

In vitro: prolonged activated partial thromboplastin time (aPTT). In vivo: thrombosis, not bleeding.

The examiner usually wants you to recognize:

  1. Venous thrombosis: deep vein thrombosis (DVT), pulmonary embolism (PE).
  2. Arterial thrombosis: stroke, transient ischemic attack (TIA), myocardial infarction in young patients.
  3. Pregnancy morbidity: recurrent miscarriage, fetal death, severe preeclampsia, placental insufficiency.
  4. Laboratory confirmation: persistent antiphospholipid antibodies on repeat testing ≥12 weeks apart.
  5. Treatment: long

Public preview

Unlock this Internal Medicine topic

Choose monthly or annual access only when those offers are supplied by the catalog.

Log in to continue
Access covers all 237 current Internal Medicine topics, dedicated question views where source material supports them, and the available Anki study deck. Subject access is $9.99/month; a $39.99 annual plan is coming soon.

A recurring monthly subscription at $9.99/subject, renews until you cancel. By subscribing you agree to our Terms and Refund Policy, ask us to start access immediately, and accept that you lose your 14-day right of withdrawal once access begins.

Anki deck locked

Unlock the subject to access its study deck.